FR2789269A1 - Dietetic composition, useful for preventing cancer of intestine and colon, comprises food fiber and red fruit extract containing anthocyanosides - Google Patents

Dietetic composition, useful for preventing cancer of intestine and colon, comprises food fiber and red fruit extract containing anthocyanosides Download PDF

Info

Publication number
FR2789269A1
FR2789269A1 FR9901662A FR9901662A FR2789269A1 FR 2789269 A1 FR2789269 A1 FR 2789269A1 FR 9901662 A FR9901662 A FR 9901662A FR 9901662 A FR9901662 A FR 9901662A FR 2789269 A1 FR2789269 A1 FR 2789269A1
Authority
FR
France
Prior art keywords
red fruit
fruit extract
extract
dietetic composition
dietary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9901662A
Other languages
French (fr)
Other versions
FR2789269B1 (en
Inventor
Dominique Dufour
Henri Pourrat
Aimee Gaillard Pourrat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferlux SA
Original Assignee
Ferlux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferlux SA filed Critical Ferlux SA
Priority to FR9901662A priority Critical patent/FR2789269B1/en
Publication of FR2789269A1 publication Critical patent/FR2789269A1/en
Application granted granted Critical
Publication of FR2789269B1 publication Critical patent/FR2789269B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

Dietetic composition (A) comprises a mixture of food fiber (I) and at least one extract (II) of red fruit, containing anthocyanosides (III). An Independent claim is also included for a method for preparing (A) by direct mixing of (I) and (II) at ambient temperature.

Description

i COMPOSITION DIETETIQUE A BASE D'EXTRAIT(S) DE FRUITi DIETETIC COMPOSITION BASED ON FRUIT EXTRACT (S)

ROUGE, PROCEDE DE FABRICATION ET UTILISATION DE LADITE COMPOSITION  RED, MANUFACTURING METHOD AND USE OF SAID COMPOSITION

L'invention a pour objet une composition diététique à base d'extrait(s) de fruit rouge. Elle concerne également le procédé de fabrication, de même que  The subject of the invention is a dietary composition based on extract (s) of red fruit. It also relates to the manufacturing process, as well as

l'utilisation de ladite composition.  the use of said composition.

Dans la suite de la description et dans les revendications, on désigne par fruits rouges, les baies de sureaux (Sambucus nigra), les baies de cassis (Ribes  In the following description and in the claims, the term “red fruits” means elderberries (Sambucus nigra), blackcurrant berries (Ribes

nigrum), les groseilles (Ribes rubrum), les mûres (Morus nigra), le raisin, et plus particulièrement les myrtilles (Vaccinium myrtillus et autres espèces du genre Vaccinium), sans toutefois que cette liste soit limitative.15 Il est connu que les fruits rouges sont riches en pigments appelés anthocyanosides, dont on a prouvé qu'ils avaient des propriétés sur le système circulatoire sanguin. Ils présentent en effet une action vasomotrice provenant d'une restauration ou d'une augmentation des flux ioniques au niveau des membranes20 cellulaires et plus particulièrement d'une modification du flux de calcium. En outre, ils améliorent les fonctionnements microvasculaires en agissant notamment sur la  nigrum), currants (Ribes rubrum), blackberries (Morus nigra), grapes, and more particularly blueberries (Vaccinium myrtillus and other species of the genus Vaccinium), although this list is not exhaustive.15 It is known that red fruits are rich in pigments called anthocyanosides, which have been proven to have properties on the blood circulatory system. They in fact exhibit a vasomotor action originating from a restoration or an increase in ionic fluxes at the level of cell membranes and more particularly from a modification of the calcium flux. In addition, they improve microvascular functioning by acting in particular on the

perméabilité des capillaires, l'augmentation étant de cette manière une des premières manifestations du processus inflammatoire.  permeability of the capillaries, the increase being in this way one of the first manifestations of the inflammatory process.

Par ailleurs, il est connu que les anthocyanosides exercent une action inhibitrice vis-à-vis de l'élastase, enzyme protéolytique pouvant intervenir dans la  Furthermore, it is known that anthocyanosides exert an inhibitory action with respect to elastase, a proteolytic enzyme which can intervene in the

dégradation du tissu conjonctif et du collagène.  breakdown of connective tissue and collagen.

Enfin, il a également été démontré que les anthocyanosides avaient une  Finally, it has also been shown that anthocyanosides have a

activité antioxydante, antiagrégant plaquettaire et antiradicalaire importante.  significant antioxidant, anti-platelet and anti-radical activity.

Ces propriétés ont été reconnues pour le traitement des troubles relatifs à la circulation rétinienne, mais aussi dans le traitement des troubles fonctionnels de la fragilité capillaire et des troubles visuels d'origine vasculaire.35 Ces propriétés ont également été mises en oeuvre dans le traitement de l'hespéranopie et de la myopie, dans les spécialités pharmaceutiques 2 commercialisées sous les marques DIFRAREL 100 et DIFRAREL E par les  These properties have been recognized for the treatment of disorders relating to the retinal circulation, but also in the treatment of functional disorders of capillary fragility and visual disorders of vascular origin.35 These properties have also been used in the treatment of hesperanopia and myopia, in the pharmaceutical specialties 2 marketed under the brands DIFRAREL 100 and DIFRAREL E by

Laboratoires LEURQUIN MEDIOLANUM.LEURQUIN MEDIOLANUM Laboratories.

D'après les propriétés reconnues des anthocyanosides, le Demandeur a constaté que les extraits de fruits rouges contenant des anthocyanosides pouvaient être judicieusement mélangés avec des fibres alimentaires à courte chaîne, chacun de ces deux composants présentant un effet synergique et étant susceptibles d'agir notamment comme facteurs préventifs de la prolifération cancéreuse au niveau de l'intestin et du colon.10 Plus précisément, l'invention concerne une composition diététique à base d'extrait(s) de fruit rouge caractérisée en ce qu'elle comprend en mélange * des fibres alimentaires,  Based on the recognized properties of anthocyanosides, the Applicant has found that extracts of red fruits containing anthocyanosides can be judiciously mixed with short-chain dietary fibers, each of these two components having a synergistic effect and being capable of acting in particular as preventive factors for cancerous proliferation in the intestine and the colon.10 More specifically, the invention relates to a dietary composition based on extract (s) of red fruit characterized in that it comprises a mixture * of dietary fiber,

* au moins, un extrait de fruit rouge renfermant des anthocyanosides.  * at least one red fruit extract containing anthocyanosides.

Selon une première caractéristique de l'invention, les fibres alimentaires sont choisies dans le groupe comprenant l'inuline et les oligosaccharides, seuls ou  According to a first characteristic of the invention, the dietary fibers are chosen from the group comprising inulin and oligosaccharides, alone or

en mélange.in mixture.

Les oligosaccharides sont obtenus par hydrolyse fractionnée de polyosides naturels et notamment de l'inuline, ou de lactose dans le cas des galacto-  The oligosaccharides are obtained by fractional hydrolysis of natural polysaccharides and in particular of inulin, or of lactose in the case of galacto-

oligosaccharides. Avantageusement, les oligosaccharides sont choisis dans le groupe  oligosaccharides. Advantageously, the oligosaccharides are chosen from the group

comprenant les fructo-oligosaccharides (FOS), les oligo-fructoses et les galacto- oligosaccharides.  including fructo-oligosaccharides (FOS), oligo-fructoses and galacto-oligosaccharides.

Plus précisément, les oligosaccharides sont composés de 2 à 7 molécules et se divisent en trois classes principales: * les fructo- oligosaccharides (FOS) sont composés de 1 à 3 molécules de fructose liées à une molécule de saccharose; * les oligo-fructoses sont composés de 2 à 6 molécules de fructose liées à une molécule de glucose ou de 2 à 6 molécules de fructose liées à un fructose réducteur; * les galacto-oligosaccharides sont composés de 2 à 5 molécules de  More precisely, oligosaccharides are composed of 2 to 7 molecules and are divided into three main classes: * fructo-oligosaccharides (FOS) are composed of 1 to 3 molecules of fructose linked to a molecule of sucrose; * oligo-fructoses are composed of 2 to 6 molecules of fructose linked to a glucose molecule or 2 to 6 molecules of fructose linked to a reducing fructose; * galacto-oligosaccharides are composed of 2 to 5 molecules of

galactose, liées à une molécule de glucose.  galactose, linked to a glucose molecule.

Les propriétés de ces fibres ont largement été décrites. On leur attribue notamment un rôle dans l'augmentation de la motricité intestinale, du fait que ces fibres de faible poids moléculaire ne sont pas digérées dans l'intestin grêle, mais5 sont assimilées dans la partie terminale du colon. De plus, leur structure à courte chaîne présente l'avantage de ne provoquer aucune irritation de la paroi intestinale  The properties of these fibers have been widely described. In particular, they are attributed a role in increasing intestinal motility, because these low molecular weight fibers are not digested in the small intestine, but are assimilated in the terminal part of the colon. In addition, their short chain structure has the advantage of not causing any irritation of the intestinal wall.

susceptible d'entraîner la libération de radicaux libres.  likely to result in the release of free radicals.

Avantageusement, les oligosaccharides choisis sont des fructo-  Advantageously, the oligosaccharides chosen are fructo-

oligosaccharides.oligosaccharides.

En effet, il est connu que les FOS restaurent la balance microbienne intestinale en accroissant la flore bifidogène. De plus, la flore bifidogène rétablie par la consommation de FOS provoque une diminution du pH intestinal, facteur qui15 paraît favorable à la prévention des cancers coliques. En outre, les FOS présentent des propriétés de rétention sélective de certains minéraux (calcium, zinc, cuivre) et  Indeed, it is known that FOS restore the intestinal microbial balance by increasing the bifidogenic flora. In addition, the bifidogenic flora restored by the consumption of FOS causes a decrease in the intestinal pH, a factor which seems favorable to the prevention of colon cancer. In addition, FOS have selective retention properties of certain minerals (calcium, zinc, copper) and

d'assimilation contrôlée des triacyl glycérols et des phospholipides dans le sang.  controlled assimilation of triacyl glycerols and phospholipids in the blood.

L'effet synergique des anthocyanosides et des FOS peut donc être identifié.  The synergistic effect of anthocyanosides and FOS can therefore be identified.

Il semble en effet intéressant de combiner l'activité antiradicalaire et antioxydante des anthocyanosides à la capacité des FOS à restaurer la balance microbienne intestinale et à abaisser le pH intestinal. La composition diététique de l'invention peut ainsi être avantageusement utilisée, sans que ce soit limitatif, dans la prévention de la prolifération cancéreuse de l'intestin et du colon.25  It indeed seems interesting to combine the anti-free radical and antioxidant activity of anthocyanosides with the capacity of FOS to restore the intestinal microbial balance and to lower the intestinal pH. The dietary composition of the invention can thus be advantageously used, without being limiting, in the prevention of cancerous proliferation of the intestine and the colon.

L'extrait de fruits rouges entrant dans la composition diététique de l'invention est avantageusement un extrait de myrtilles.  The extract of red fruits used in the dietary composition of the invention is advantageously an extract of blueberries.

En pratique, cet extrait de myrtilles peut se présenter sous toutes formes  In practice, this extract of blueberries can come in all forms

sèches conventionnelles, et notamment sous forme de poudre.  conventional dry, and in particular in powder form.

Bien entendu, l'extrait de myrtilles pourra avoir subi tout procédé de purification connu de l'homme du métier, de sorte à augmenter son titre en anthocyanosides.35  Of course, the bilberry extract may have undergone any purification process known to those skilled in the art, so as to increase its titer in anthocyanosides. 35

On utilisera avantageusement des extraits de myrtilles titrés de 0 à 100 % en monomères anthocyanosidiques ou de 0 à 100 % en complexe catécho-  Advantageously, extracts of blueberries titrated from 0 to 100% in anthocyanoside monomers or from 0 to 100% in catecho- complex will be used.

anthocyanique. Dans une forme avantageuse, la composition diététique de l'invention comprend entre 0,1 et 30 % en poids d'extrait de fruit rouge. Pour une concentration inférieure à 0,1 % en poids d'extrait, on ne relève aucun effet synergique entre les anthocyanosides contenues dans l'extrait et les  anthocyanin. In an advantageous form, the dietary composition of the invention comprises between 0.1 and 30% by weight of red fruit extract. For a concentration of less than 0.1% by weight of extract, there is no synergistic effect between the anthocyanosides contained in the extract and the

fibres alimentaires.dietary fiber.

Pour une concentration supérieure à 30 % en poids d'extrait, l'effet synergique obtenu reste constant, un surdosage n'apporte donc aucun bénéfice.  For a concentration greater than 30% by weight of extract, the synergistic effect obtained remains constant, an overdose therefore brings no benefit.

Il est à souligner que l'extrait de myrtille et les FOS se présentent avantageusement sous toute forme sèche, qui garantit une stabilité optimale de  It should be noted that the bilberry extract and the FOS are advantageously in any dry form, which guarantees optimal stability of

chacun des composés, et ainsi leur activité.  each of the compounds, and thus their activity.

L'invention concerne également le procédé de fabrication de la  The invention also relates to the method for manufacturing the

composition selon lequel à température ambiante, on mélange l'extrait de fruit rouge et les fibres alimentaires.  composition according to which at room temperature, the red fruit extract and the dietary fibers are mixed.

Avant mélange, les anthocyanosides et les FOS sont tamisés. On obtient alors un mélange de poudres, qui peut être conditionné sous toutes formes sèches,  Before mixing, the anthocyanosides and the FOS are sieved. A mixture of powders is then obtained, which can be packaged in all dry forms,

en sachets par exemple, ou être soumis à une étape de compression, de sorte à obtenir des comprimés.  in sachets for example, or be subjected to a compression step, so as to obtain tablets.

L'invention et les avantages qui en découlent ressortiront mieux des exemples de réalisation suivants.  The invention and the advantages which result therefrom will emerge more clearly from the following exemplary embodiments.

On prépare deux formulations diététiques conformes à l'invention dont la  Two dietary formulations are prepared in accordance with the invention, the

composition est la suivante.composition is as follows.

Exemple IExample I

Composition à 4 % - 40 mg d'extrait de myrtilles - 1 g de fructo-oligosaccharides ou d'inuline  Composition at 4% - 40 mg of blueberry extract - 1 g of fructo-oligosaccharides or inulin

Exemple 2Example 2

Composition à 15 % - 40 mg d'extrait de myrtilles - 2 g de fructo-oligosaccharides ou d'inuline Dans les deux exemples, on tamise préalablement les deux poudres. L'extrait anthocyanosidique de myrtilles est tamisé sur un seuil de coupure de 180 microns. En ce qui les concerne, les FOS sont tamisés sur un seuil de coupure de  Composition at 15% - 40 mg of blueberry extract - 2 g of fructo-oligosaccharides or inulin In the two examples, the two powders are sieved beforehand. The anthocyanosidic extract of blueberries is sieved over a cutoff threshold of 180 microns. As far as they are concerned, the FOS are screened on a cutoff threshold of

710 micromètres.710 micrometers.

On effectue tout d'abord un prémélange en mélangeant la totalité de l'extrait de myrtilles avec la moitié de la quantité de FOS. Le mélange final est  First, a premix is made by mixing all of the blueberry extract with half the amount of FOS. The final mixture is

obtenu en mélangeant le prémélange avec la seconde moitié de FOS.  obtained by mixing the premix with the second half of FOS.

On conditionne ensuite le mélange ainsi obtenu sous forme de sachets étanches. Les conditions du mélange et du conditionnement, sous hygrométrie contrôlée et inférieure à 10 %, sont les facteurs essentiels pour garantir la stabilité  The mixture thus obtained is then packaged in the form of sealed bags. The mixing and packaging conditions, under controlled humidity and below 10%, are the essential factors to guarantee stability

du produit, et donc son activité.of the product, and therefore its activity.

Les avantages de l'invention ressortent bien de la description.  The advantages of the invention appear clearly from the description.

On notera en particulier l'effet synergique d'un extrait de fruit rouge riche en anthocyanosides et de fibres alimentaires, composés qui se positionnent notamment comme facteurs favorables à la prévention de la prolifération  Note in particular the synergistic effect of a red fruit extract rich in anthocyanosides and dietary fibers, compounds which are positioned in particular as factors favorable to the prevention of proliferation

cancéreuse de l'intestin et du colon.  intestinal and colon cancer.

On notera en outre la simplicité du procédé de fabrication de la  Note also the simplicity of the manufacturing process of the

composition objet de l'invention.composition object of the invention.

Claims (9)

REVENDICATIONQS 1/ Composition diététique à base d'extrait(s) de fruit rouge caractérisée en ce qu'elle comprend en mélange: * des fibres alimentaires,  1 / Dietetic composition based on extract (s) of red fruit characterized in that it comprises in mixture: * dietary fibers, * au moins un extrait de fruit rouge renfermant des anthocyanosides.  * at least one red fruit extract containing anthocyanosides. 2/ Composition diététique selon la revendication 1, caractérisée en ce que les fibres alimentaires sont choisies dans le groupe comprenant l'inuline et les  2 / dietetic composition according to claim 1, characterized in that the dietary fibers are chosen from the group comprising inulin and oligosaccharides, seuls ou en mélange.  oligosaccharides, alone or in mixture. 3/ Composition diététique selon la revendication 2, caractérisée en ce que les oligosaccharides sont choisis dans le groupe comprenant les fructo-  3 / dietetic composition according to claim 2, characterized in that the oligosaccharides are chosen from the group comprising fructo- oligosaccharides (FOS), les oligo-fructoses et les galactooligosaccharides.15  oligosaccharides (FOS), oligo-fructoses and galactooligosaccharides. 15 4/ Composition diététique selon l'une des revendications précédentes, caractérisée en ce que l'extrait de fruit rouge se présente sous forme de poudre.  4 / dietetic composition according to one of the preceding claims, characterized in that the red fruit extract is in powder form. / Composition diététique selon la revendication 3, caractérisée en ce  / Dietetic composition according to claim 3, characterized in qu'elle comprend entre 0,1 et 30 % en poids d'extrait de fruit rouge.  that it comprises between 0.1 and 30% by weight of red fruit extract. 6/ Composition diététique selon l'une des revendications précédentes, caractérisée en ce que l'extrait de fruit rouge est un extrait de myrtilles.  6 / Dietetic composition according to one of the preceding claims, characterized in that the red fruit extract is an extract of blueberries. 7/ Procédé de fabrication de la composition diététique objet de l'une des revendications 1 à 6, caractérisé en ce que l'on mélange directement, à température  7 / A method of manufacturing the dietary composition object of one of claims 1 to 6, characterized in that one mixes directly, at temperature ambiante, l'extrait de fruit rouge et les fibres alimentaires.  ambient, red fruit extract and dietary fiber. 8/ Procédé de fabrication selon la revendication précédente, caractérisé en ce que l'on tamise chacune des deux poudres d'extrait de fruit rouge et de fibres  8 / manufacturing process according to the preceding claim, characterized in that each of the two powders of red fruit extract and fibers is sieved alimentaires avant mélange.food before mixing. 9/ Procédé de fabrication selon la revendication 8, caractérisé en ce que le  9 / The manufacturing method according to claim 8, characterized in that the mélange est ensuite conditionné sous forme de sachets.  mixture is then packaged in the form of sachets. / Procédé selon les revendications 7 à 9, caractérisé en ce que le mélange  / Method according to claims 7 to 9, characterized in that the mixture et le conditionnement sont effectués sous hygrométrie contrôlée.  and packaging are carried out under controlled humidity. 11/ Utilisation de la composition diététique objet des revendications 1 à 6  11 / Use of the dietary composition which is the subject of claims 1 to 6 pour la prévention de la prolifération cancéreuse de l'intestin et du colon.  for the prevention of cancerous proliferation of the intestine and the colon. DEPOSANT: FERLUXAPPLICANT: FERLUX MANDATAIRE: CABINET LAURENT et CHARRAS  REPRESENTATIVE: LAURENT CABINET and CHARRAS
FR9901662A 1999-02-09 1999-02-09 DIETETIC COMPOSITION BASED ON RED FRUIT EXTRACT (S), MANUFACTURING METHOD AND USE OF SAID COMPOSITION Expired - Fee Related FR2789269B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9901662A FR2789269B1 (en) 1999-02-09 1999-02-09 DIETETIC COMPOSITION BASED ON RED FRUIT EXTRACT (S), MANUFACTURING METHOD AND USE OF SAID COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901662A FR2789269B1 (en) 1999-02-09 1999-02-09 DIETETIC COMPOSITION BASED ON RED FRUIT EXTRACT (S), MANUFACTURING METHOD AND USE OF SAID COMPOSITION

Publications (2)

Publication Number Publication Date
FR2789269A1 true FR2789269A1 (en) 2000-08-11
FR2789269B1 FR2789269B1 (en) 2001-06-15

Family

ID=9541914

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9901662A Expired - Fee Related FR2789269B1 (en) 1999-02-09 1999-02-09 DIETETIC COMPOSITION BASED ON RED FRUIT EXTRACT (S), MANUFACTURING METHOD AND USE OF SAID COMPOSITION

Country Status (1)

Country Link
FR (1) FR2789269B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002238A1 (en) * 2002-06-26 2004-01-08 Nestec S.A. Nutritional composition for detoxification and cancer prevention
US20100323041A1 (en) * 2002-08-30 2010-12-23 Biopharmacopae Design International Inc. Methods and therapeutic compositions comprising plant extracts for the treatment of cancer
CN101297692B (en) * 2008-05-26 2013-04-03 昆明理工大学 Extraction of glycosides from Vaccinium dunalianum Wight var. dunalianum and use thereof in health products

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984003216A1 (en) * 1983-02-16 1984-08-30 Carl Axel Virdalm A preparation for suppressing states of illness in the digestive system
JPS6343959A (en) * 1986-08-11 1988-02-25 San Ei Chem Ind Ltd Method for stabilizing anthocyanin dye
EP0573777A1 (en) * 1992-05-11 1993-12-15 INDENA S.p.A. Oral pharmaceutical compositions containing anthocyanosides
EP0692252A1 (en) * 1994-06-14 1996-01-17 "Raffinerie Tirlemontoise", société anonyme: Composition containing inulin or oligofructose for use in cancer treatment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984003216A1 (en) * 1983-02-16 1984-08-30 Carl Axel Virdalm A preparation for suppressing states of illness in the digestive system
JPS6343959A (en) * 1986-08-11 1988-02-25 San Ei Chem Ind Ltd Method for stabilizing anthocyanin dye
EP0573777A1 (en) * 1992-05-11 1993-12-15 INDENA S.p.A. Oral pharmaceutical compositions containing anthocyanosides
EP0692252A1 (en) * 1994-06-14 1996-01-17 "Raffinerie Tirlemontoise", société anonyme: Composition containing inulin or oligofructose for use in cancer treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 012, no. 258 (C - 513) 20 July 1988 (1988-07-20) *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002238A1 (en) * 2002-06-26 2004-01-08 Nestec S.A. Nutritional composition for detoxification and cancer prevention
AU2003280504B2 (en) * 2002-06-26 2009-11-19 Nestec S.A. Nutritional composition for detoxification and cancer prevention
US20100323041A1 (en) * 2002-08-30 2010-12-23 Biopharmacopae Design International Inc. Methods and therapeutic compositions comprising plant extracts for the treatment of cancer
CN101297692B (en) * 2008-05-26 2013-04-03 昆明理工大学 Extraction of glycosides from Vaccinium dunalianum Wight var. dunalianum and use thereof in health products

Also Published As

Publication number Publication date
FR2789269B1 (en) 2001-06-15

Similar Documents

Publication Publication Date Title
Chew et al. In-vitro evaluation of kenaf seed oil in chitosan coated-high methoxyl pectin-alginate microcapsules
EP1909593B1 (en) Pea protein composition
JP4782104B2 (en) Pecer derived from acerola fruit and its use
CA2895353A1 (en) Prophylactic/therapeutic agent for dry eye
JP2008500027A (en) Berry oil and products
DE102008032828A1 (en) Tryptophan-containing peptides from alpha-lactalbumin with hypotensive and vasoprotective action for biofunctional foods
Nguyen et al. Production of xyloglucan component extracted from tamarind (Tamarindus indica) seeds using microwave treatment for seed decortication
US20070237859A1 (en) Drink containing functional ingredients capable of preventing degenerative phenomena caused by oxidizing agents
Pérez et al. Interest of black carob extract for the development of active biopolymer films for cheese preservation
CA2666960A1 (en) Ultra high pressure modified proteins and uses thereof
JP2004189698A (en) Bleaching agent, antioxidant, collagenase inhibitor, hyaluronidase inhibitor, age resister, skin lotion, cosmetic and food
FR2789269A1 (en) Dietetic composition, useful for preventing cancer of intestine and colon, comprises food fiber and red fruit extract containing anthocyanosides
FR2792831A1 (en) COMPOSITION FOR COSMETIC AND / OR DIETETIC USE COMPRISING A MIXTURE OF LYCOPENE AND OLIVE LEAF EXTRACT
CA2359475A1 (en) Method for purifying a red fruit extract containing anthocyanosides
EP2627192B1 (en) Hydrolysates of animal proteins of marine origin with neuroprotective properties
KR101617320B1 (en) Royal jelly beverage composition having improved dispersability in water and method for preparing the same
Wang et al. Effects of glycation with chitooligosaccharide on digestion and fermentation processes of lactoferrin in vitro
EP1245580A1 (en) Fibre containing composition for enteral nutrition
KR20210153178A (en) Composition for promoting absorption of collagen and synthesis of collagen
WO1999065459A1 (en) Cereal plant extract based on polar lipids
Cornelia et al. Encapsulation of soursop (Annona muricata Linn.) leaf tea extract using natural mucilage
Ragazzo-Sánchez et al. Utilization of by-products of endemic fruits: Encapsulation of proteolytic extracts of guamara (Bromelia pinguin) and cocuixtle (Bromelia karatas) by electrospraying
CA2123585A1 (en) Polar lipidic composition from plants
CA2778170A1 (en) Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
JP2020152651A (en) Novel salmon-derived proteoglycan

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091030